Cigna Corp (CI)
316.64
+4.59 (1.47%)
NYSE · Last Trade: May 31st, 6:55 AM EDT
Detailed Quote
Previous Close | 312.05 |
---|---|
Open | 312.28 |
Bid | 288.88 |
Ask | 320.00 |
Day's Range | 310.05 - 319.25 |
52 Week Range | 262.03 - 370.83 |
Volume | 2,732,239 |
Market Cap | 107.69B |
PE Ratio (TTM) | 17.59 |
EPS (TTM) | 18.0 |
Dividend & Yield | 6.040 (1.91%) |
1 Month Average Volume | 1,815,213 |
Chart
About Cigna Corp (CI)
Cigna Corporation is a global health service company that provides a comprehensive range of health insurance products and services. The company operates across various sectors, including medical, dental, disability, life, and accident insurance, offering coverage to individuals and families, as well as employer-sponsored group plans. Additionally, Cigna delivers integrated health services, such as pharmacy management, behavioral health support, and wellness programs, focusing on improving health outcomes and enhancing the overall well-being of its members. Through its innovative approaches, Cigna aims to create a seamless healthcare experience while addressing the diverse needs of its customers. Read More
News & Press Releases

Via Benzinga · May 30, 2025

Manila () May 30, 2025 -- The article, titled “Best Insurance Providers in the Philippines for Expats”, offers in-depth reviews of global insurers.
Via Prodigy · May 30, 2025

Manila () May 30, 2025 -- Pacific Prime has launched an enhanced online resource designed to help individuals, families, and organizations secure the right international health insurance with confidence and clarity.
Via Prodigy · May 30, 2025

Cigna trades at $313 per share and has moved almost in lockstep with the market over the last six months. The stock has lost 7.3% while the S&P 500 is down 2.5%. This may have investors wondering how to approach the situation.
Via StockStory · May 29, 2025
Via The Motley Fool · May 27, 2025
The Ninth Circuit affirmed a decision denying the FTC's application to block Microsoft's acquisition of Activision Blizzard. The FTC dropped the case and Trump's personnel changes may impact future tech regulation and antitrust enforcement.
Via Benzinga · May 23, 2025
The Federal Trade Commission voted 3-0 Thursday to dismiss a lawsuit against PepsiCo Inc. that accused the beverage giant of offering preferential pricing to major retailers, marking a significant shift from Biden-era corporate scrutiny under the new Trump administration.
Via Benzinga · May 23, 2025
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 6.3% in the afternoon session after Cigna Group's Evernorth division introduced a monthly $200 price cap for weight-loss medications such as Wegovy and Zepbound, a move that could significantly disrupt pricing in the weight loss drug market.
Via StockStory · May 22, 2025
Truist noted on Thursday that the $200/month price point is "highly attractive compared to other price points in the market," including Hims & Hers' compounded Semaglutide, Wegovy, and Liraglutide subscription programs.
Via Stocktwits · May 22, 2025
Cigna’s Evernorth has reached agreements with Eli Lilly and Novo Nordisk to reduce prices for GLP-1 weight-loss drugs Wegovy and Zepbound
Via Stocktwits · May 22, 2025
US healthcare stocks came under pressure after CMS said it would expand Medicare Advantage audits and partner with the HHS Inspector General to recover past overpayments.
Via Stocktwits · May 21, 2025
Via Benzinga · May 20, 2025
Expansion of insurance partnerships increases access to mental health care across Southern California
Via Press Release Distribution Service · May 20, 2025
Get insights into the top gainers and losers in the S&P500 index of Tuesday's pre-market session.
Via Chartmill · May 20, 2025
Trump signed an executive order to lower drug prices, which could hit pharmacy benefit managers (PBMs) hard. PBMs have come under scrutiny for opaque pricing practices. Mark Cuban calls PBMs a racket.
Via Benzinga · May 19, 2025
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Friday as we examine the latest happenings in today's session.
Via Chartmill · May 16, 2025
Health insurance company Cigna (NYSE:CI) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 14.4% year on year to $65.5 billion. Its non-GAAP profit of $6.74 per share was 6.2% above analysts’ consensus estimates.
Via StockStory · May 16, 2025
Via Benzinga · May 15, 2025
May 15, 2025 -- Icarus In Idaho Celebrates Opening to Deliver Personalized, Evidence-Based Care for Mental Health and Addiction in a Tranquil Boise Setting
Via 24-7 Press Release · May 15, 2025
Empire Psychiatry, a fast-rising name in the world of mental wellness, is proud to announce its launch as New York’s go-to destination for thoughtful, personalized psychiatric care. With a commitment to making mental health services more accessible, human-centered, and stigma-free, Empire Psychiatry is already making waves among patients and practitioners alike.
Via GetFeatured · May 14, 2025
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Tuesday.
Via Chartmill · May 13, 2025
Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session.
Via Chartmill · May 13, 2025
Bernie Sanders wonders if Trump is "serious about making real change rather than just issuing a press release."
Via Benzinga · May 13, 2025
Trump on Monday signed an executive order aimed at reducing the cost of prescription drugs.
Via Benzinga · May 13, 2025